Magnesiocard

Magnesium L-Aspartate Hydrochloride Trihydrate, the active ingredient in Magnesiocard, is a magnesium salt presented as an oral supplement for systemic use. It helps restore normal magnesium levels in individuals with deficiency or increased loss and is formulated for oral administration without prescription.

GNH USA supplies Magnesiocard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magnesiocard provides magnesium supplementation to address conditions associated with low magnesium levels. - Magnesium deficiency: helps restore normal serum magnesium concentrations. - Hypomagnesemia: supports correction of low blood magnesium. - Muscle cramps related to low magnesium: may reduce frequency and intensity of cramps.

Magnesiocard is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Diarrhea: loose stools occurring after ingestion. - Abdominal discomfort: mild stomach pain or cramping. - Nausea: feeling of queasiness. - Flatulence: increased gas production. - Metallic taste: transient after swallowing. - Constipation: occasional difficulty passing stool.

Serious or Rare Side Effects: - Hypermagnesemia: elevated blood magnesium leading to cardiac arrhythmia. - Hypotension: unusually low blood pressure. - Muscle weakness: reduced strength or fatigue. - Respiratory depression: slowed breathing in severe cases.

Before using Magnesiocard, consider the following safety measures. - Assess renal function: adjust use in patients with impaired kidney function. - Monitor serum magnesium: avoid excessive levels during prolonged therapy. - Avoid in severe heart block: use only under medical supervision. - Do not combine with high‑dose calcium supplements without professional advice. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store below 25°C: keep in the original pack, protect from moisture.

Magnesiocard may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Antacids containing calcium or aluminum: reduce magnesium absorption. - Aminoglycoside antibiotics: increase risk of neuromuscular blockade. - Loop diuretics: may increase urinary magnesium loss.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may raise serum magnesium levels. - Potassium‑sparing diuretics: additive risk of hypermagnesemia. - Bisphosphonates: decreased absorption if taken concurrently.